Perricone Md Acne Relief Retinol Treatment and Moisturizer

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product should be shaken well before use. It is recommended to apply a thin, even layer to the skin in the evening. For optimal results, the application should follow cleansing with ACNE RELIEF Gentle & Soothing Cleanser, ensuring that the skin is thoroughly cleaned prior to application.

The product may be applied to the entire affected area one to three times daily. It is advisable to start with one application daily, gradually increasing to two or three times daily as needed or as directed by a healthcare professional. In cases where bothersome dryness or peeling occurs, the frequency of application should be reduced to once a day or every other day.

For new users, a sensitivity test is recommended. This involves applying the product sparingly to one or two small affected areas during the first three days. If no discomfort is experienced, the user may then proceed to follow the previously stated application directions.

Contraindications

The use of this product is contraindicated in patients who are concurrently using another topical acne medication, as this may increase the risk of skin irritation and dryness. In the event of irritation, it is advised to limit the use to one topical acne medication at a time.

Warnings and Precautions

For external use only. This product is not intended for ingestion.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

No specific laboratory tests are recommended for monitoring during the use of this product. However, healthcare professionals should remain vigilant for any adverse reactions or complications that may arise from its use.

Side Effects

For external use only. No specific adverse reactions or side effects have been reported in clinical trials or postmarketing experiences. Patients should be advised to use the product as directed and to consult a healthcare professional if any unexpected reactions occur.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Perricone Md Acne Relief Retinol Treatment and Moisturizer (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients do not have specific geriatric use considerations, dosage adjustments, safety concerns, or special precautions associated with the use of Perricone MD Acne Relief Retinol Treatment and Moisturizer. As such, healthcare providers may administer this product to geriatric patients without the need for modifications or additional monitoring specific to this population. However, standard clinical judgment should always be applied when treating elderly patients, taking into account their overall health status and any concurrent medications.

Pregnancy

The product is contraindicated in pregnancy due to potential risks to the fetus associated with its use. Pregnant patients or those planning to become pregnant should avoid using this product to mitigate any possible adverse fetal outcomes. It is essential for healthcare professionals to counsel women of childbearing potential regarding these risks and to consider alternative treatment options that are safer during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced renal function. It is essential for healthcare professionals to monitor renal function regularly in these patients. Dosage adjustments should be based on creatinine clearance levels to ensure safety and efficacy. Special considerations are warranted for patients with severe renal impairment to mitigate potential risks associated with treatment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial for healthcare professionals to document all findings and interventions thoroughly and to report any adverse events or overdose cases to the appropriate regulatory authorities as per local guidelines.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

When discussing the use of this product, it is important for healthcare providers to inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. Therefore, if patients experience any irritation, they should be instructed to limit their use to one topical acne medication at a time to minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommendation to apply a thin, even layer to the skin in the evening. Patients should cover the entire affected area with this layer one to three times daily, starting with one application daily and gradually increasing to two or three times daily as needed or directed by a clinician. If patients experience bothersome dryness or peeling, they should reduce the application frequency to once a day or every other day.

Clinicians should counsel patients on the potential for increased skin irritation and dryness when using this product in conjunction with other topical acne medications. It is advised that new users perform a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days. If no discomfort occurs, patients can then follow the standard application instructions.

Drug Information (PDF)

This file contains official product information for Perricone Md Acne Relief Retinol Treatment and Moisturizer, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)